Clinical and patient reported outcomes in multiple sclerosis patients on disease modifying therapies

被引：0
|
作者：
Fernandes, L. [1 ]
Horton, M. [2 ]
Russell, M. [1 ]
Lily, O. [1 ]
Ford, H. L. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Leeds Ctr Neurosci, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P812
引用
收藏
页码：417 / 418
页数：2
相关论文
共 50 条
  • [31] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Simona Lattanzi
    Maura Danni
    Ruja Taffi
    Raffaella Cerqua
    Giulia Carlini
    Alessandra Pulcini
    Leandro Provinciali
    Mauro Silvestrini
    Journal of Neurology, 2017, 264 : 2325 - 2329
  • [32] Disease modifying therapies prevent secondary progression in multiple sclerosis patients
    Bergamaschi, Roberto
    Amato, Maria Pia
    Quaglini, Silvana
    Tavazzi, Eleonora
    Paolicelli, Damiano
    Portaccio, Emilio
    Troiano, Maria
    MULTIPLE SCLEROSIS, 2008, 14 : S32 - S32
  • [33] Patient-reported loneliness and pessimism are associated with EDSS progression after discontinuation of disease modifying therapies in multiple sclerosis
    Vaughn, C.
    Kavak, K.
    Weinstock-Guttman, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 145 - 146
  • [34] The evaluation of disease modifying therapies for side effects in patients with multiple sclerosis
    Agaoglu, J.
    Kale, N.
    Onder, G.
    Emir, C.
    Tanik, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 240 - 240
  • [35] Factors Influencing Patients' Choices of Disease Modifying Therapies in Multiple Sclerosis
    Sharrack, Basil
    Elias, Reem
    Reuber, Markus
    NEUROLOGY, 2012, 78
  • [36] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Lattanzi, Simona
    Danni, Maura
    Taffi, Ruja
    Cerqua, Raffaella
    Carlini, Giulia
    Pulcini, Alessandra
    Provinciali, Leandro
    Silvestrini, Mauro
    JOURNAL OF NEUROLOGY, 2017, 264 (11) : 2325 - 2329
  • [37] Breast Cancer in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, M. H.
    Patel, D.
    Obeidat, A. Z.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 99 - 100
  • [38] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Elena Grebenciucova
    Amy Pruitt
    Current Neurology and Neuroscience Reports, 2017, 17
  • [39] Switching disease modifying therapies in multiple sclerosis patients: a study of 110 patients
    Morra, VB
    Coppola, G
    Lanzillo, R
    Vacca, G
    Pagano, A
    Orefice, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S235 - S235
  • [40] Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection
    Maghbooli, Zhila
    Hosseinpour, Hesham
    Fattahi, Mohammad Reza
    Varzandi, Tarlan
    Hamtaeigashi, Sara
    Mohammad-nabi, Sara
    Aghababaei, Yasaman
    Sahraian, Mohammad Ali
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
12345